+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "In Silico Clinical Trials"

In Silico Clinical Trials Market Report 2023-2033 - Product Thumbnail Image

In Silico Clinical Trials Market Report 2023-2033

  • Report
  • September 2023
  • 231 Pages
  • Global
From
in Silico Clinical Trials Global Market Report 2024 - Product Thumbnail Image

in Silico Clinical Trials Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
From
From
From
From
  • 10 Results (Page 1 of 1)
Loading Indicator

In Silico Clinical Trials are a type of clinical trial that uses computer simulations and models to evaluate the safety and efficacy of a drug or medical device. This type of trial is conducted virtually, without the need for physical testing on humans or animals. It is used to assess the safety and efficacy of a drug or device before it is tested on humans. In Silico Clinical Trials can be used to reduce the cost and time associated with traditional clinical trials, as well as to reduce the risk of adverse events. In Silico Clinical Trials are becoming increasingly popular in the clinical trial industry, as they offer a cost-effective and efficient way to evaluate the safety and efficacy of a drug or device. They are also used to identify potential drug-drug interactions and to assess the potential for drug-drug interactions. Companies in the In Silico Clinical Trials market include Simulations Plus, Certara, Entelos, and In Silico Biosciences. Show Less Read more